Pediatric Drugs

Papers
(The TQCC of Pediatric Drugs is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus69
Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy43
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting38
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-234
Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children30
Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient30
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria29
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study28
The Use of Linaclotide in Children with Functional Constipation or Irritable Bowel Syndrome: A Retrospective Chart Review22
Lidocaine Infusions for Pain Management in Pediatrics22
Phentermine/Topiramate: Pediatric First Approval21
Sodium Thiosulfate: Pediatric First Approval20
Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses20
Viloxazine: Pediatric First Approval19
An Update on CFTR Modulators as New Therapies for Cystic Fibrosis19
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance19
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years19
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients19
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis18
An Update of Pharmacological Management in Children with Functional Constipation18
Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial18
Managing Patient Pressure to Prescribe Antibiotics in the Clinic16
Ranibizumab: A Review in Retinopathy of Prematurity16
Pain Management in Children: NSAID Use in the Perioperative and Emergency Department Settings15
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations14
Impact of Antiseizure Medications on Appetite and Weight in Children14
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis13
Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review11
Metamizole Use in Children: Analysis of Drug Utilisation and Adverse Drug Reactions at a German University Hospital between 2015 and 202011
A Mixed-Methods Analysis of Medication Safety Incidents Reported in Neonatal and Children’s Intensive Care11
Targeted Therapy for Pediatric Psoriasis11
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clin10
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia10
Teriflunomide: Pediatric First Approval10
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study10
Effect of Mirtazapine on Nausea in Children with Functional Nausea and Functional Dyspepsia Postprandial Distress Syndrome10
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years10
Medication and Fluid Management of Pediatric Sepsis and Septic Shock9
Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity9
Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart9
Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children9
Deferred Consent in Neonatal Clinical Research: Why, When, How?8
Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects8
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary8
Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis8
Pharmacotherapy for Spinal Muscular Atrophy in Babies and Children: A Review of Approved and Experimental Therapies8
Immunosuppression Regimens for Intestinal Transplantation in Children8
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis8
A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants8
Lonapegsomatropin: Pediatric First Approval8
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review8
Immunotherapies for Pediatric Solid Tumors: A Targeted Update7
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study7
Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives7
Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children7
The Effect of Alfentanil on Emergence Delirium Following General Anesthesia in Children: A Randomized Clinical Trial7
Haloperidol and Quetiapine for the Treatment of ICU-Associated Delirium in a Tertiary Pediatric ICU: A Propensity Score-Matched Cohort Study7
Interventions to Reduce Pediatric Prescribing Errors in Professional Healthcare Settings: A Systematic Review of the Last Decade7
Targeted Therapy in Pediatric AML: An Evolving Landscape7
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population7
Treatment Options in Pediatric Behçet’s Disease7
0.55187010765076